Leading strategic business development and partnering activities, including driving commercial growth for services, instruments, and products at Curi Bio. Curi is a leading developer of human stem cell-based biological systems (with complementary instrumentation & AI/ML data platforms) for therapeutic discovery with a focus on cell and gene therapy applications.

With a wide variety of industry experience ranging from large Pharma to small CROs, I have served in a number of scientific/technical & business development roles. At ChemPartner, I serve as the “Global Lead” and provide overarching leadership for Global Account Teams comprised of local BDs. My goal is to design and execute strategic alliances that bring value to both ChemPartner and its clients - this may be through collaborative 3rd party alliances. It has always been my goal to provide more efficient operations and capabilities to our customers.

Home office-based. GM for North America (~50% monthly national and int’l travel). General manager, & primary scientific/medical liaison for North America. Various roles (scientific BusDev focused) in product R&D, sales and cardiac assay services. Daily Activities: manage North American sales and scientific teams, neuron product manager, operational management (Ncardia/Axiogenesis has achieved 40-90% growth every year during my >4 years there). Manage national, international, policy and business development projects with key opinion leaders, FDA, etc. Represent Ncardia during national and international projects, meetings, and conferences. “Lobbyist” to push global policy changes in cardiac safety pharmacology (via HESI/FDA CiPA initiative).

• Provide on-site scientific application support and training on company products, thereby contributing substantially to customer satisfaction. • Support sales in the achievement of the regional sales target by delivering product line specific pre- and post-sales related customer support activities. • Manage national (and international) scientific and business development projects• Representative for FDA/HESI projects (CiPA & Biomarkers of neurotoxicity)• Remain up to date with Axiogenesis product lines and state of the art scientific advances relevant to supporting product advances and customer needs.• Remotely direct German laboratory personnel for product development and assay servicesOTHER RESPONSIBILITIES: • Represent Axiogenesis during national and international projects, meetings, and conferences• Perform on-site demonstrations of Axiogenesis products• Acquire and maintain scientific and competitive knowledge and market segment overview for support of customers, sales and service. Keep up to date with the scientific community. Train other colleagues on new products/applications as necessary. • Provide high quality pre- and post-sales support by customer visits, product/application demonstrations, seminars, and online teleconferences.• Feedback to sales & marketing market conditions and product opportunities. • Work effectively with Sales and Service in regional/key accounts of responsibility. • Provide high quality post-sales support by training and visiting customers, delivery of email support, organization of user meetings and general follow up of customer’s requests.

I was a project manager for a contract research organization (CRO) specializing in cardiac safety pharmacology. There I was responsible for integrating electrophysiological assays (micro-electrode array (MEA) and cardiac contractility technologies, manual patch clamp) and establishing vendor relationships for human cardiomyocyte stem cells (hiPSC). I also developed software to accelerate compound/drug screening during preclinical development for ion channel activity/cardiac toxicity in a GLP environment. I was heavily involved in day-to-day interactions with our many clients (sales, protocol development, marketing, reporting and documentation, etc) as well as the management responsibilities of running all cardiomyocyte services.

During my time at Pfizer, I was a postdoctoral fellow/Michael J Fox Foundation Fellow working in the Neuroscience Research Unit in Cambridge, MA. I worked on the LRRK2 project team (PD therapeutic target) to support small molecule development and further our understanding the molecular mechanisms behind Parkinson's Disease. My project management efforts drove the biology within the LRRK2 project team. I was focused on novel target/substrate identification, characterization, and development of cellular, rodent, and proteomic-based assays. I worked closely with design chemists, structural biology and biophysics, and was able to maintain multiple external collaborations.

My dissertation work investigated the molecular signals regulating neutrophil granule exocytosis. My technical abilities included proteomics and mass spectrometry (sample prep, running samples, optimization, maintenance, bioinformatic data analysis), HPLC, immunoblot, confocal microscopy, cell culture, PCR, and many other biochemical and molecul biology applications. At UL I was in the Kidney Disease Program where I completed my doctoral work under UL professor and Chief of Nephrology at the V.A. Medical Center, Kenneth McLeish, MD. My nephrology experience was focused specifically on clinical diagnosis and treatment of diseases of the glomerulus.